Insider Shareholders with Direct Ownership of Protara Therapeutics, Inc. (TARA)
This section provides a comprehensive overview of the insiders with direct ownership of Protara Therapeutics, Inc. (TARA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protara Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jesse Shefferman
CEO and President |
226,665 | 81,818 | 994,022 $4.44 Million | 17 |
Jan 24, 2025
Added 6.14%
|
| 30,000 | 0 | 198,000 $885,060 | 3 |
Jun 30, 2022
Added 4.81%
|
|
|
Jacqueline Zummo
Chf Scientific Operations Off |
81,500 | 35,528 | 126,639 $566,076 | 13 |
Jan 24, 2025
Added 16.21%
|
|
Jathin Bandari
Chief Medical Officer |
57,200 | 7,996 | 56,704 $253,466 | 8 |
Jan 19, 2024
Reduced 4.83%
|
|
Patrick Fabbio
Chief Financial Officer |
45,500 | 3,061 | 45,500 $203,385 | 3 |
Jan 24, 2025
Added 34.06%
|
|
Hannah Fry
VP, Controller |
48,400 | 14,188 | 38,942 $174,070 | 10 |
Jan 24, 2025
Added 19.61%
|
|
Blaine Davis
Chief Financial Officer |
14,100 | 5,081 | 20,662 $92,359 | 2 |
Jul 15, 2022
Reduced 19.74%
|
|
Martin Sebastian Olivo
Chief Medical Officer |
9,893 | 0 | 14,344 $64,117 | 1 |
Jun 10, 2021
Added 25.59%
|